GLP-1 Drugs (Ozempic/Wegovy/Mounjaro): A Bounded Tool, Not a Shortcut Past Baseline

Summary

GLP-1 drugs work — they are among the most-studied metabolic medicines we have and produce ~15–20% weight loss — but they are a **maintenance treatment, not a cure**, with real costs (muscle loss, GI effects, weight regain on stopping); the recovery-posture move is to exhaust the genuine lower-side-effect levers first (protein, whole-food/low-energy-density eating, water/soup preloads) and escalate **without shame** if those are insufficient — while ignoring both the pharma hype and the "natural Ozempic" counter-market.